Eric is a highly accomplished and passionate leader with 30 years of experience in medical sales and marketing with a particular focus on diagnostics. As Chief Executive Officer of Kiyatec Inc., he demonstrates exceptional leadership in the functional oncology space, overseeing sales, marketing, and operations. Eric has a proven track record of success, evident in his ability to secure fundraising for ongoing initiatives, rebrand products for patient-focused launches, and strategically restructure organizations for optimal performance.

In his previous roles, including Senior Vice President at LumiraDx and Chief Commercial Officer/GM at Lumos Diagnostics, Eric showcased his expertise in expanding market share, establishing international distribution networks, and driving significant revenue growth. His work at Astute Medical, Singulex, and Biosite Corporation further highlights his ability to lead successful product launches, secure funding rounds, and achieve remarkable growth in the highly competitive medical diagnostics industry.

Eric’s strategic foresight, fundraising prowess, and unwavering commitment to bringing potentially lifesaving diagnostics to market make him a driving force in advancing healthcare innovation and improving patient outcomes.

Scott Isacksen is an accomplished strategist and sales leader with three decades of experience in effective business development, growth, and team leadership. In his current role as Vice President, Sales, Scott is leveraging his business acumen and knack for building and empowering high-performing teams to solidify Kiyatec’s reputation as a leader in functional precision oncology. And with his talent for shaping comprehensive commercial infrastructures, he’s perfectly positioned to shepherd Kiyatec toward a future of lasting success.

Throughout his career, Scott has consistently identified new business opportunities, devised market strategies, and cultivated enduring stakeholder relationships. In his most recent role as Senior Sales Director at Myovant Sciences, he played a crucial role in building the initial sales team and launching a novel prostate cancer treatment. Scott’s wealth of experience in launching and growing startups, along with his successful track record of bringing over 20 products to market, has firmly established him as an influential and dynamic leader. With his deep understanding of the pharmaceutical, biotech, and diagnostic landscape, he continues to make a significant impact by driving innovation, accelerating growth, and reshaping the trajectory of the organizations he collaborates with.

Jennifer serves as the Senior Director of Laboratory Operations, where she oversees all aspects of laboratory performance, regulatory compliance, and team development. With over 13 years of experience in clinical and medical laboratory settings, she brings extensive expertise in managing high-complexity operations. Jennifer holds a degree in Biology and is certified in Molecular Biology by the American Society for Clinical Pathology, combining a strong scientific foundation with proven leadership.

Throughout her career, she has successfully launched molecular laboratories, validated advanced diagnostic assays, and ensured compliance with CAP, CLIA, COLA, and New York State regulations. Guided by a passion for advancing patient care through precise and timely diagnostics, Jennifer leads operations at Kiyatec with a focus on regulatory excellence and high-quality testing, delivering actionable insights that support personalized treatment decisions.

Aaron Carlson, PhD, is a biomedical engineer with over 20 years of experience in 3D tumor models, stem cell-based tissue engineering, regenerative medicine, and biomaterials. As Head of Science at Kiyatec, he leads all scientific initiatives, including new test development, external collaborations, data analysis, and publication strategy, and serves as technical supervisor of Kiyatec’s CLIA-certified laboratory.

Aaron joined Kiyatec in 2019 as a scientist in Pharma Services, advancing drug discovery programs for pharmaceutical and biotech partners using Kiyatec’s 3D cell culture platform. He now drives innovation across the organization to support product improvement, laboratory automation, and future product launches.

Aaron holds a BSE in Biomedical Engineering and Computer Science from Duke University and a PhD in Biomedical Engineering from Rutgers University. He also completed postdoctoral training at Duke University and previously held research and product development scientist roles at Zylö Therapeutics and Affinergy, LLC.